Robuta

https://adisinsight.springer.com/trials/700006637?error=cookies_not_supported&code=f6b8af5f-e156-40d1-abde-7635aa75805a A phase II study of OSI-774 (Tarceva) [erlotinib] in combination with capecitabine in previously... This phase II trial is designed to investigate the effectiveness of Tarceva (OSI-774) combined with capecitabine in treating patients with metastatic https://adisinsight.springer.com/trials/700038657?error=cookies_not_supported&code=8a377667-dff8-46d5-82e8-db5e7459b6c9 A Phase 2 Randomized Open-Label Study of Neratinib Versus Lapatinib Plus Capecitabine for the... This non-inferiority trial is comparing the efficacy and tolerability of neratinib [HKI-272; Wyeth] with lapatinib [Tykerb, Tyverb] + capecitabine [Xeloda] in https://adisinsight.springer.com/drugsafety/803911351?error=cookies_not_supported&code=2ef6cd91-cabf-4850-89a2-cc3e8461a1d5 Capecitabine/Oxaliplatin - AdisInsight A cohort of 32 patients (median age 42 years, 66% male) with locally advanced rectal cancer received total neoadjuvant therapy consisting of short-course capecitabineoxaliplatinadisinsight https://adisinsight.springer.com/trials/700271151?error=cookies_not_supported&code=af478869-05ca-40de-9eaf-f1fbfa636201 Phase I study of a combination of capecitabine plus CPT-11 (CC therapy) in patients with metastatic... To assess the feasibility of the combination of capecitabine plus irinotecan (CC therapy) in patients with metastatic colon cancer refractory to oxaliplatin https://researchportalplus.anu.edu.au/en/publications/multicenter-randomized-phase-ii-clinical-trial-comparing-neoadjuv/ Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and... phase iiclinical trialmulticenterrandomized https://research.birmingham.ac.uk/en/projects/effect-of-renal-impairment-on-the-pharmacokinetics-of-capecitabin/ Effect of Renal Impairment on the Pharmacokinetics of Capecitabine in Cancer Patients - University... renal impairmenton the https://pubmed.ncbi.nlm.nih.gov/25416687/ Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally... These results suggest that TEF is worthy of evaluation as an arm in a phase III trial or as a backbone regimen for new targeted agents in advanced GC.... docetaxelplusoxaliplatin https://adisinsight.springer.com/trials/700134078?error=cookies_not_supported&code=62518004-390b-4e38-a0e1-02d84c69702d Phase II trial of oral vinorelbine in combination with capecitabine as first line therapy in women... This trial is entitled "Phase II trial of oral vinorelbine in combination with capecitabine as first line therapy in women with previously untreated HER2 https://www.fda.gov/advisory-committees/pediatric-advisory-committee/xeloda-capecitabine-briefing-materials Xeloda (capecitabine) Briefing Materials | FDA Briefing materials for the April 12, 2016 meeting of the FDA's Pediatric Advisory Committee briefing materialsxelodacapecitabinefda https://www.cochrane.org/evidence/CD011220_benefits-capecitabine-hormone-receptor-positive-compared-hormone-receptor-negative-breast-cancer Benefits of capecitabine in hormone receptor-positive compared to hormone receptor-negative breast... hormone receptor positivebenefits ofcapecitabine https://pubmed.ncbi.nlm.nih.gov/27859657/ Capecitabine and adermatoglyphia: trouble in border! Capecitabine and adermatoglyphia: trouble in border! capecitabinetroubleborder https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCT02614794&r=1 A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With... a study https://experts.arizona.edu/en/publications/capecitabine-therapy-for-refractory-metastatic-thyroid-carcinoma-/ Capecitabine therapy for refractory metastatic thyroid carcinoma: A case series - University of... thyroid carcinoma https://pubmed.ncbi.nlm.nih.gov/28182248/ Coadministration of proton pump inhibitors and the efficacy of capecitabine in patients with... Coadministration of proton pump inhibitors and the efficacy of capecitabine in patients with advanced adenocarcinoma of the small bowel or ampulla of vater proton pump inhibitorsand the https://adisinsight.springer.com/drugsafety/803239192?error=cookies_not_supported&code=1f7b1635-fa29-4b4a-ae80-94fcc443a71f Capecitabine - AdisInsight In a study, 2 patients [ages and sexes not stated] were described, out of which 1 patient developed proctitis and 1 patient developed urgencies, stool capecitabineadisinsight https://adisinsight.springer.com/drugsafety/803220972?error=cookies_not_supported&code=32f2a23c-59b3-429e-a6aa-a13bf50bfc4b Capecitabine - AdisInsight In a retrospective study, four patients [ages and sexes not stated] were described, who developed hand foot syndrome, diarrhoea, mucositis, haematologic capecitabineadisinsight https://adisinsight.springer.com/drugsafety/803347370?error=cookies_not_supported&code=88f68479-6fc4-4364-b7cc-58ee4877a1d6 Capecitabine/cobimetinib/vemurafenib - AdisInsight In a case report, two women were described, out of whom one developed acute coronary syndrome due to coronary vasospasm during treatment with capecitabine for capecitabinecobimetinibvemurafenibadisinsight https://experts.mcmaster.ca/scholarly-works/2552570 191 Phase II trial of gemcitabine and capecitabine... Learn about the scholarly work entitled 191 Phase II trial of gemcitabine and capecitabine... phase iitrialgemcitabinecapecitabine https://adisinsight.springer.com/drugsafety/803396543?error=cookies_not_supported&code=5c881ef6-b5f0-46cc-a028-f0020cf09ff5 Capecitabine/cisplatin/trastuzumab - AdisInsight An 82-year-old man developed neutropenia, cardiotoxicity and exacerbation of hand-foot syndrome during treatment with cisplatin, trastuzumab or capecitabine for capecitabinecisplatintrastuzumabadisinsight https://openresearch.surrey.ac.uk/esploro/outputs/journalArticle/Implementation-of-capecitabine-Xeloda-into-a/99514745902346 Implementation of capecitabine (Xeloda) into a cancer centre: UK experience. - University of Surrey Switching patients from intravenous 5-FU/LV to oral capecitabine (Xeloda) for the treatment of metastatic colorectal cancer is associated with a reduction in... https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/65162-0843/ 65162-0843 Capecitabine - CanMED: NDC CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies. capecitabinendc https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-capecitabine-with-or-without-bevacizumab-for-colorectal-cancer A trial looking at capecitabine with or without bevacizumab for colorectal cancer (QUASAR 2) This trial compared capecitabine and bevacizumab with capecitabine alone for bowel (colorectal) cancer. https://www.cancer.gov/research/participate/clinical-trials/intervention/capecitabine Clinical Trials Using Capecitabine - NCI NCI supports clinical trials that test new and more effective ways to treat cancer. Find clinical trials studying capecitabine. clinical trialsusingcapecitabinenci https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/69097-0948/ 69097-0948 Capecitabine - CanMED: NDC CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies. capecitabinendc https://researchportal.helsinki.fi/fi/publications/adjuvant-capecitabine-for-early-breast-cancer-15-year-overall-sur/ Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized... https://portal.fis.tum.de/en/publications/capecitabine-for-treatment-of-advanced-hepatocellular-carcinoma-2/ Capecitabine for treatment of advanced hepatocellular carcinoma - Technical University of Munich hepatocellular carcinomatechnical universitycapecitabinetreatmentadvanced https://adisinsight.springer.com/drugsafety/803722067?error=cookies_not_supported&code=3b404bee-28c6-4b6e-8b74-9873a77db0d6 Capecitabine/oxaliplatin - AdisInsight A 64-year-old man developed myelosuppression during treatment with capecitabine and oxaliplatin for triple malignancy of the stomach, rectum and liver [routes, capecitabineoxaliplatinadisinsight https://pubmed.ncbi.nlm.nih.gov/37676712/ Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish... The substantial superior outcomes in patients receiving first-line CAPTEM treatment highlight its potential as an effective treatment strategy for patients... https://adisinsight.springer.com/drugsafety/803914642?error=cookies_not_supported&code=fe2002f2-fad7-49e8-b369-8a094c07dfa3 Capecitabine/Gimeracil/oteracil/tegafur/Oxaliplatin - AdisInsight A retrospective study included 22 patients with stage IV gastric cancer and gastric outlet obstruction who underwent modified laparoscopic stomach-partitioning capecitabineoxaliplatinadisinsight https://ce.massmed.nejm.org/nejm-weekly-cme/content/tucatinib-trastuzumab-and-capecitabine-her2-positive-metastatic-breast-cancer Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer | MMS/NEJM... metastatic breast cancer https://pubmed.ncbi.nlm.nih.gov/25302025/ Capecitabine-induced cardiotoxicity: more evidence or clinical approaches to protect the patients'... Fluoropyrimidines, such as capecitabine and 5-fluorouracil, may cause cardiac toxicity. In recent years, the incidence of this side effect has increased and it... more evidence https://pubmed.ncbi.nlm.nih.gov/31881136/ Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer metastatic breasttucatinibtrastuzumabcapecitabinepositive https://adisinsight.springer.com/drugsafety/803850230?error=cookies_not_supported&code=62cee504-7e72-422d-940b-ee7172efe5fe Capecitabine, risk of metabolic acidosis - AdisInsight A safety signal of capecitabine and the risk of metabolic acidosis has been detected as a result of pharmacovigilance monitoring by the Saudi Food and Drug metabolic acidosiscapecitabineriskadisinsight https://adisinsight.springer.com/drugsafety/801127635?error=cookies_not_supported&code=e8b4dcf1-f990-4601-990a-b09ed581afaa Capecitabine - AdisInsight A 68-year-old woman developed colitis cystica superficialis during treatment with capecitabine for metastatic bilateral breast cancer.The woman presented with a capecitabineadisinsight https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1138357/full Frontiers | Effectiveness and safety of capecitabine, irinotecan and panitumumab in advanced... Introduction: Capecitabine, irinotecan, and panitumumab (CAPIRI-P) is a controversial regimen for metastatic colorectal cancer, with concerns regarding the e... frontierseffectivenesssafetycapecitabineirinotecan https://portal.fis.tum.de/en/publications/lapatinib-versus-lapatinib-plus-capecitabine-as-second-line-treat/ Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth... second line https://pubmed.ncbi.nlm.nih.gov/21052661/ Phase II study of radiopeptide 177Lu-octreotate and capecitabine therapy of progressive... The addition of capecitabine radiosensitizing chemotherapy does not increase the minimal toxicity of (177)Lu-octreotate radiopeptide therapy and led to an ORR... phase iistudy https://connect.mayoclinic.org/discussion/capecitabine-xoleda-and-weight-gain/?commentsorder=newest Capecitabine (Xeloda) and Weight Gain | Mayo Clinic Connect I started Capecitabine on June 9, 2022. Since starting this medicine, I have gained almost 20 pounds (within 2 months). Latest weight taken today at... weight gainmayo cliniccapecitabinexelodaconnect https://pubmed.ncbi.nlm.nih.gov/28211921/ Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular... Preliminary studies suggest that capecitabine may be safe and effective in HCC patients. The aim of this study was to retrospectively evaluate the safety and... supportive care https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b59e98c-5b34-4b93-90f6-20526f4d4f88&audience=professional DailyMed - CAPECITABINE- capecitabine tablet, film coated dailymedcapecitabinetabletfilmcoated https://adisinsight.springer.com/drugsafety/803928059?error=cookies_not_supported&code=23db559b-551f-4d2c-94af-6454daf7d578 Capecitabine/Peposertib - AdisInsight Three patients [age and sex not stated] with rectal cancer in a phase Ib study received neoadjuvant capecitabine-based chemoradiation combined with peposertib capecitabineadisinsight https://pmc.ncbi.nlm.nih.gov/articles/PMC4256612/ Incidence and relative risk of grade 3 and 4 diarrhoea in patients treated with capecitabine or 5-... Capecitabine is an oral fluoropyrimidine that can effectively replace infusional 5-fluorouracil (5-FU) for treatment of colorectal, gastric and breast cancer.... https://adisinsight.springer.com/trials/700392189?error=cookies_not_supported&code=b48441c3-957c-4114-85eb-9d9be9ee2178 Short-Course Radiotherapy Followed by Liposomal Irinotecan, Capecitabine, and Camrelizumab as... This study is for adults with locally advanced rectal cancer that has not spread to distant organs, and is classified as pMMR or MSS (which means it typically short coursefollowed byradiotherapy https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/68001-0643/ 68001-0643 Capecitabine - CanMED: NDC CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies. capecitabinendc https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-bortezomib-with-epirubicin-carboplatin-and-capecitabine-chemotherapy-for-cancer-where-the-food-pipe-meets-the-stomach A trial of bortezomib with epirubicin, carboplatin and capecitabine chemotherapy for cancer where... This trial looked at the drug bortezomib with chemotherapy for cancer that started where the food pipe (oesophagus) meets the stomach. https://eprints.ncl.ac.uk/206428 Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with... https://adisinsight.springer.com/trials/700057858?error=cookies_not_supported&code=08ae7530-4bd8-4c1d-a5c5-a9a448a98429 Clinical Outcomes on ErbB2+ MBC Patients Treated With Lapatinib-Capecitabine After Trastuzumab... This study is investigating the efficacy and tolerability of early versus late lapatinib + capecitabine, initiated immediately after progression on trastuzumab clinical outcomes